AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...

New research highlights middle age as a pivotal period for brain health, with significant changes in how cells remove damaged mitochondria. Defects in this recycling process have been linked to ...

Burney, beloved mother, wife, and nanny, passed away peacefully on Nov. 11, 2024, in her home in Greenbackville, after a ...

Nightmares can be caused by a range of conditions from Parkinson's to sleep apnoea - and they can even help diagnose your ...

A team of Tel Aviv University researchers claims to have made progress in the path to treating Parkinson’s disease. The team found that a variant of a protein, caused by a genetic mutation, enhances ...

AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...

Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...

Could your dreams be trying to tell you something? Discover the surprising connections between what haunts you at night and ...

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein ...

The connection between auditory or vestibular disorders and neuroinflammatory or neurodegenerative diseases has gained ...

to develop exercise equipment for Parkinson’s Disease patients in the area. One result of Hunter’s efforts includes a machine ...

Katie Fagan, Senior Program Coordinator & Clinical Social Worker at Northwestern University Parkinson’s Disease and Movement Disorders Center, joins Lisa Dent to talk about Northwestern ...